Olmesartan Comparison to Losartan in Hypertensive Subjects
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of the FDA approved blood pressure
medication olmesartan medoxomil compared to the FDA approved medication losartan potassium.